Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Behavior, Addictive | 8 | 2022 | 130 | 4.090 |
Why?
|
| Reversal Learning | 11 | 2022 | 15 | 3.310 |
Why?
|
| Decision Making | 12 | 2022 | 642 | 3.180 |
Why?
|
| Cocaine | 4 | 2022 | 76 | 2.850 |
Why?
|
| Reward | 11 | 2022 | 181 | 2.400 |
Why?
|
| Receptors, Dopamine D2 | 7 | 2014 | 57 | 1.900 |
Why?
|
| Methamphetamine | 6 | 2020 | 82 | 1.670 |
Why?
|
| Conditioning, Operant | 9 | 2022 | 73 | 1.570 |
Why?
|
| Cocaine-Related Disorders | 2 | 2020 | 34 | 1.430 |
Why?
|
| Dopamine | 8 | 2020 | 275 | 1.430 |
Why?
|
| Goals | 2 | 2020 | 67 | 1.310 |
Why?
|
| Prefrontal Cortex | 7 | 2021 | 130 | 1.300 |
Why?
|
| Substance-Related Disorders | 4 | 2021 | 394 | 1.290 |
Why?
|
| Rats | 13 | 2022 | 3992 | 1.200 |
Why?
|
| Corpus Striatum | 4 | 2020 | 86 | 1.190 |
Why?
|
| Discrimination Learning | 5 | 2014 | 63 | 1.170 |
Why?
|
| Brain | 9 | 2022 | 2216 | 1.110 |
Why?
|
| Models, Psychological | 4 | 2020 | 157 | 1.090 |
Why?
|
| Neurosciences | 3 | 2021 | 52 | 1.060 |
Why?
|
| Animals | 41 | 2022 | 26590 | 1.030 |
Why?
|
| Rats, Long-Evans | 7 | 2022 | 48 | 0.930 |
Why?
|
| Putamen | 2 | 2013 | 13 | 0.920 |
Why?
|
| Habits | 4 | 2021 | 15 | 0.870 |
Why?
|
| Behavior, Animal | 7 | 2018 | 373 | 0.860 |
Why?
|
| Impulsive Behavior | 5 | 2020 | 281 | 0.850 |
Why?
|
| Central Nervous System Stimulants | 2 | 2017 | 216 | 0.840 |
Why?
|
| Receptors, Dopamine D3 | 3 | 2020 | 18 | 0.820 |
Why?
|
| Mental Disorders | 2 | 2017 | 371 | 0.780 |
Why?
|
| Astrocytes | 1 | 2020 | 139 | 0.730 |
Why?
|
| Feedback, Physiological | 2 | 2019 | 62 | 0.660 |
Why?
|
| Brain Chemistry | 1 | 2018 | 121 | 0.660 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 168 | 0.640 |
Why?
|
| Amphetamine-Related Disorders | 2 | 2013 | 27 | 0.560 |
Why?
|
| Self Administration | 3 | 2020 | 73 | 0.540 |
Why?
|
| Positron-Emission Tomography | 7 | 2022 | 329 | 0.530 |
Why?
|
| Endocannabinoids | 3 | 2021 | 27 | 0.530 |
Why?
|
| Male | 27 | 2022 | 40988 | 0.510 |
Why?
|
| Blinking | 1 | 2014 | 17 | 0.510 |
Why?
|
| Frontal Lobe | 2 | 2013 | 130 | 0.500 |
Why?
|
| Synaptic Transmission | 3 | 2017 | 222 | 0.440 |
Why?
|
| Neuroimaging | 1 | 2013 | 113 | 0.420 |
Why?
|
| Choice Behavior | 3 | 2020 | 160 | 0.420 |
Why?
|
| Serotonin | 1 | 2013 | 218 | 0.400 |
Why?
|
| Paranoid Disorders | 2 | 2021 | 5 | 0.390 |
Why?
|
| Neurobiology | 2 | 2020 | 10 | 0.370 |
Why?
|
| Mesencephalon | 2 | 2020 | 64 | 0.360 |
Why?
|
| Nucleus Accumbens | 2 | 2020 | 113 | 0.330 |
Why?
|
| Motivation | 2 | 2022 | 288 | 0.320 |
Why?
|
| Cognition Disorders | 3 | 2015 | 236 | 0.290 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 183 | 0.290 |
Why?
|
| Time Factors | 5 | 2016 | 5214 | 0.280 |
Why?
|
| Analysis of Variance | 4 | 2016 | 912 | 0.250 |
Why?
|
| Monoacylglycerol Lipases | 2 | 2021 | 3 | 0.240 |
Why?
|
| Phencyclidine | 2 | 2014 | 7 | 0.230 |
Why?
|
| Cognition | 3 | 2014 | 571 | 0.230 |
Why?
|
| Sex Characteristics | 2 | 2017 | 319 | 0.230 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2022 | 5 | 0.220 |
Why?
|
| Synapses | 2 | 2015 | 265 | 0.220 |
Why?
|
| Receptors, GABA | 1 | 2022 | 10 | 0.210 |
Why?
|
| Schizophrenia | 2 | 2016 | 464 | 0.210 |
Why?
|
| Photic Stimulation | 3 | 2014 | 494 | 0.210 |
Why?
|
| Algorithms | 2 | 2021 | 1830 | 0.200 |
Why?
|
| Models, Neurological | 2 | 2019 | 405 | 0.200 |
Why?
|
| Culture | 1 | 2021 | 53 | 0.200 |
Why?
|
| Humans | 15 | 2022 | 86678 | 0.200 |
Why?
|
| Cues | 1 | 2022 | 175 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 2 | 2022 | 503 | 0.190 |
Why?
|
| Neostriatum | 1 | 2020 | 26 | 0.190 |
Why?
|
| Uncertainty | 2 | 2020 | 71 | 0.190 |
Why?
|
| Consummatory Behavior | 1 | 2020 | 1 | 0.190 |
Why?
|
| Extinction, Psychological | 1 | 2020 | 19 | 0.180 |
Why?
|
| Ventral Tegmental Area | 1 | 2020 | 43 | 0.180 |
Why?
|
| Attitude to Health | 1 | 2021 | 220 | 0.180 |
Why?
|
| Membrane Glycoproteins | 1 | 2022 | 428 | 0.180 |
Why?
|
| Glutamic Acid | 1 | 2020 | 152 | 0.180 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2020 | 44 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 1961 | 0.180 |
Why?
|
| Diphtheria Toxin | 1 | 2019 | 20 | 0.180 |
Why?
|
| Learning | 1 | 2022 | 281 | 0.170 |
Why?
|
| Glycerides | 1 | 2019 | 17 | 0.170 |
Why?
|
| Arachidonic Acids | 1 | 2019 | 39 | 0.170 |
Why?
|
| Eating | 1 | 2020 | 166 | 0.170 |
Why?
|
| Ventral Striatum | 1 | 2018 | 3 | 0.170 |
Why?
|
| Age Factors | 3 | 2020 | 1852 | 0.170 |
Why?
|
| Amygdala | 1 | 2019 | 84 | 0.170 |
Why?
|
| Benzazepines | 2 | 2017 | 89 | 0.160 |
Why?
|
| Neurons | 2 | 2019 | 1547 | 0.160 |
Why?
|
| Schizophrenic Psychology | 2 | 2016 | 129 | 0.150 |
Why?
|
| Delusions | 1 | 2017 | 11 | 0.150 |
Why?
|
| Association Learning | 1 | 2017 | 34 | 0.150 |
Why?
|
| Oxazines | 1 | 2016 | 13 | 0.140 |
Why?
|
| Disease Susceptibility | 2 | 2014 | 193 | 0.140 |
Why?
|
| Food Deprivation | 1 | 2016 | 24 | 0.140 |
Why?
|
| Dopamine Agents | 1 | 2016 | 29 | 0.140 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 267 | 0.140 |
Why?
|
| Interneurons | 1 | 2017 | 93 | 0.140 |
Why?
|
| Feeding Behavior | 1 | 2019 | 324 | 0.140 |
Why?
|
| Receptor, Cannabinoid, CB1 | 3 | 2021 | 11 | 0.140 |
Why?
|
| Autistic Disorder | 1 | 2017 | 147 | 0.140 |
Why?
|
| Female | 10 | 2022 | 44550 | 0.140 |
Why?
|
| Air Pollutants, Occupational | 1 | 2015 | 6 | 0.130 |
Why?
|
| Phenols | 1 | 2015 | 40 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2018 | 575 | 0.130 |
Why?
|
| Benzhydryl Compounds | 1 | 2015 | 48 | 0.130 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 27 | 0.130 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2015 | 23 | 0.130 |
Why?
|
| Food Preferences | 1 | 2014 | 26 | 0.120 |
Why?
|
| Biogenic Monoamines | 2 | 2011 | 8 | 0.120 |
Why?
|
| Sex Chromosomes | 1 | 2014 | 57 | 0.120 |
Why?
|
| Computational Biology | 1 | 2017 | 528 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 2231 | 0.110 |
Why?
|
| HIV Infections | 1 | 2022 | 772 | 0.110 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2013 | 14 | 0.110 |
Why?
|
| Visceral Pain | 1 | 2013 | 6 | 0.110 |
Why?
|
| Caudate Nucleus | 1 | 2013 | 16 | 0.110 |
Why?
|
| Spinal Cord | 1 | 2014 | 249 | 0.110 |
Why?
|
| Memory, Short-Term | 3 | 2015 | 220 | 0.110 |
Why?
|
| Brain Mapping | 1 | 2016 | 549 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2016 | 3362 | 0.110 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2013 | 45 | 0.110 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2012 | 12 | 0.110 |
Why?
|
| Protein Binding | 1 | 2016 | 1457 | 0.110 |
Why?
|
| Homovanillic Acid | 1 | 2012 | 35 | 0.110 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2012 | 35 | 0.110 |
Why?
|
| Feedback, Sensory | 1 | 2012 | 25 | 0.100 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2011 | 16 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2016 | 1078 | 0.100 |
Why?
|
| Cebus | 1 | 2011 | 17 | 0.100 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 123 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 916 | 0.090 |
Why?
|
| Biomarkers | 2 | 2016 | 1718 | 0.090 |
Why?
|
| Models, Biological | 1 | 2016 | 1749 | 0.090 |
Why?
|
| Risk-Taking | 1 | 2010 | 148 | 0.080 |
Why?
|
| Mice | 5 | 2022 | 11356 | 0.080 |
Why?
|
| Basal Ganglia | 1 | 2008 | 42 | 0.080 |
Why?
|
| Memory Disorders | 1 | 2007 | 69 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 549 | 0.070 |
Why?
|
| Motor Activity | 2 | 2020 | 327 | 0.070 |
Why?
|
| Sex Factors | 2 | 2022 | 1055 | 0.070 |
Why?
|
| Pattern Recognition, Visual | 1 | 2007 | 151 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 584 | 0.060 |
Why?
|
| Neuropsychological Tests | 3 | 2015 | 502 | 0.060 |
Why?
|
| Exploratory Behavior | 2 | 2017 | 44 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2014 | 506 | 0.050 |
Why?
|
| Amidohydrolases | 1 | 2021 | 18 | 0.050 |
Why?
|
| Masks | 1 | 2021 | 29 | 0.050 |
Why?
|
| Infection Control | 1 | 2021 | 115 | 0.050 |
Why?
|
| Optogenetics | 1 | 2020 | 30 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 3095 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2022 | 459 | 0.040 |
Why?
|
| Cannabinoid Receptor Antagonists | 1 | 2019 | 2 | 0.040 |
Why?
|
| Health Policy | 1 | 2021 | 180 | 0.040 |
Why?
|
| Lithium Chloride | 1 | 2019 | 2 | 0.040 |
Why?
|
| Lipoprotein Lipase | 1 | 2019 | 14 | 0.040 |
Why?
|
| Drug-Seeking Behavior | 1 | 2019 | 10 | 0.040 |
Why?
|
| Benzodioxoles | 1 | 2019 | 16 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2020 | 369 | 0.040 |
Why?
|
| TRPV Cation Channels | 1 | 2019 | 15 | 0.040 |
Why?
|
| Central Nervous System Depressants | 1 | 2019 | 45 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2020 | 308 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2019 | 153 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 639 | 0.040 |
Why?
|
| Piperidines | 1 | 2019 | 181 | 0.040 |
Why?
|
| Prepulse Inhibition | 1 | 2017 | 4 | 0.040 |
Why?
|
| Stereotyped Behavior | 1 | 2017 | 11 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2017 | 9 | 0.040 |
Why?
|
| Methylazoxymethanol Acetate | 1 | 2016 | 1 | 0.040 |
Why?
|
| Ethanol | 1 | 2019 | 249 | 0.040 |
Why?
|
| Inflammation | 1 | 2022 | 923 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 67 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1807 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2016 | 110 | 0.030 |
Why?
|
| Dendritic Spines | 1 | 2015 | 15 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 740 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 318 | 0.030 |
Why?
|
| Anxiety | 1 | 2017 | 287 | 0.030 |
Why?
|
| Sex-Determining Region Y Protein | 1 | 2014 | 3 | 0.030 |
Why?
|
| Pyramidal Cells | 1 | 2015 | 80 | 0.030 |
Why?
|
| Serotonergic Neurons | 1 | 2014 | 4 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 503 | 0.030 |
Why?
|
| Taste | 1 | 2014 | 28 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2014 | 50 | 0.030 |
Why?
|
| Social Behavior | 1 | 2017 | 294 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 263 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1221 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 1540 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2013 | 290 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1753 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2015 | 296 | 0.030 |
Why?
|
| Dibenzocycloheptenes | 1 | 2011 | 1 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2013 | 145 | 0.020 |
Why?
|
| Muscimol | 1 | 2010 | 18 | 0.020 |
Why?
|
| GABA Agonists | 1 | 2010 | 20 | 0.020 |
Why?
|
| Baclofen | 1 | 2010 | 15 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 840 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 224 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 1852 | 0.020 |
Why?
|
| Probability | 1 | 2010 | 355 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 492 | 0.020 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2007 | 11 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 25659 | 0.020 |
Why?
|
| Raclopride | 1 | 2007 | 3 | 0.020 |
Why?
|
| Dopamine D2 Receptor Antagonists | 1 | 2007 | 7 | 0.020 |
Why?
|
| Dopamine Antagonists | 1 | 2007 | 35 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2007 | 34 | 0.020 |
Why?
|
| Reaction Time | 1 | 2007 | 309 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 5420 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 7998 | 0.010 |
Why?
|